King Medicaid Rebate Data Sought By SEC; Subpoena Includes Altace Rebates
Executive Summary
The Securities & Exchange Commission is asking King to provide information about its Medicaid rebate calculations as part of a broad subpoena disclosed by the company March 11
You may also be interested in...
King Names COO Markison Acting CEO; President Macione Steps Down
King Pharmaceuticals Chief Operating Officer Brian Markison has been named acting president and CEO
King Names COO Markison Acting CEO; President Macione Steps Down
King Pharmaceuticals Chief Operating Officer Brian Markison has been named acting president and CEO
King Ups Medicaid Rebate Underpayment Estimate To $65 Mil.; CEO To Depart
King Pharmaceuticals is raising its estimated Medicaid rebate underpayments by $18.9 mil. to $65.4 mil. following the completion of an internal audit, CFO Jim Lattanzi said during a Feb. 19 conference call